Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-Cell Lung Cancer

Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2016.09.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Comparison of Biweekly and Triweekly Therapy With Docetaxel and Irinotecan for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer

The Showa University Journal of Medical Sciences
2007English

Comprehensive Analysis ofUGT1APolymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2011English

A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

A Phase II Study of Oral Etoposide in Elderly Patients With Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1989English

The Efficacy of Amrubicin Third‐line Chemotherapy in Patients With Relapsed Extensive‐disease Small‐cell Lung Cancer: A Retrospective and Historical Study in a Single Institute

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Unexpected Favorable Outcome to Etoposide and Cisplatin in a Small Cell Lung Cancer Transformed Patient: A Case Report

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy